These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12594937)

  • 21. An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.
    Rice AE; Latchman YE; Balint JP; Lee JH; Gabitzsch ES; Jones FR
    Cancer Gene Ther; 2015 Sep; 22(9):454-62. PubMed ID: 26337747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is uterine cervical cancer a potentially preventable sexually transmitted disease?
    Mgone CS
    P N G Med J; 1998 Jun; 41(2):47-50. PubMed ID: 10934543
    [No Abstract]   [Full Text] [Related]  

  • 23. The warts and all approach to tackling cervical cancer.
    Bonn D; Bradbury J
    Lancet; 1998 Mar; 351(9105):810. PubMed ID: 9519967
    [No Abstract]   [Full Text] [Related]  

  • 24. A human papillomavirus type 16 vaccine.
    Duggirala MK; Cuddihy MT
    N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12672871
    [No Abstract]   [Full Text] [Related]  

  • 25. [The detection of p53 gene and HPV16 oncogene in cervical carcinoma].
    Sun Y; Si L
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):29-32. PubMed ID: 7781112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence sketchy on circumcision and cervical cancer link.
    Hill G
    Can Fam Physician; 2003 Dec; 49():1591. PubMed ID: 14708919
    [No Abstract]   [Full Text] [Related]  

  • 27. WHO pushes first cervical cancer vaccine.
    Public Health Rep; 1999; 114(3):211. PubMed ID: 10476988
    [No Abstract]   [Full Text] [Related]  

  • 28. Human papillomavirus vaccines.
    Stanley MA
    Curr Opin Mol Ther; 2002 Feb; 4(1):15-22. PubMed ID: 11883690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.
    Wang SS; Hildesheim A; Gao X; Schiffman M; Herrero R; Bratti MC; Sherman ME; Barnes WA; Greenberg MD; McGowan L; Mortel R; Schwartz PE; Zaino RJ; Glass AG; Burk RD; Karacki P; Carrington M
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):419-20. PubMed ID: 11927505
    [No Abstract]   [Full Text] [Related]  

  • 30. A human papillomavirus type 16 vaccine.
    Yoo SS; Whitmore SE
    N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12678023
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.
    Fernando GJ; Murray B; Zhou J; Frazer IH
    Clin Exp Immunol; 1999 Mar; 115(3):397-403. PubMed ID: 10193409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors.
    Bermúdez-Humarán LG; Cortes-Perez NG; Lefèvre F; Guimarães V; Rabot S; Alcocer-Gonzalez JM; Gratadoux JJ; Rodriguez-Padilla C; Tamez-Guerra RS; Corthier G; Gruss A; Langella P
    J Immunol; 2005 Dec; 175(11):7297-302. PubMed ID: 16301635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence sketchy on circumcision and cervical cancer link.
    Bhimji A; Harrison D
    Can Fam Physician; 2003 Dec; 49():1591-2. PubMed ID: 14708920
    [No Abstract]   [Full Text] [Related]  

  • 34. [HPV vaccination--a possibility for prevention of cervical cancer].
    Paavonen J
    Duodecim; 2002; 118(21):2159-60. PubMed ID: 12486951
    [No Abstract]   [Full Text] [Related]  

  • 35. [Possibilities of vaccination against HPV infections in cervix carcinoma].
    Gissmann L
    Zentralbl Gynakol; 2001 May; 123(5):299-301. PubMed ID: 11449623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for human papillomavirus vaccine development: emerging HPV vaccines.
    Hines JF; Ghim SJ; Jenson AB
    Curr Opin Obstet Gynecol; 1998 Feb; 10(1):15-9. PubMed ID: 9484624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prophylactic and therapeutic vaccine therapy in papillomavirus infections].
    Vinatier D; Cosson M; Dufour P
    Gynecol Obstet Fertil; 2000 May; 28(5):370-84. PubMed ID: 10893881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillomaviruses in human cancers.
    zur Hausen H
    Proc Assoc Am Physicians; 1999; 111(6):581-7. PubMed ID: 10591087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papillomavirus vaccines.
    Duggan-Keen MF; Brown MD; Stacey SN; Stern PL
    Front Biosci; 1998 Dec; 3():D1192-208. PubMed ID: 9835649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.